XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Common Stock
Private Placement 2024
Common Stock
Additional Paid-in Capital
Private Placement 2024
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Private Placement 2024
Total
Balance beginning at Jun. 30, 2024   $ 53   $ 450,473 $ (79) $ (329,444)   $ 121,003
Balance beginning (in shares) at Jun. 30, 2024   53,245,824            
Gross proceeds from issuance of common stock for cash $ 1   $ 5,999       $ 6,000  
Gross proceeds from issuance of common stock for cash (in shares) 1,500,000              
Commissions and other offering costs       (45)       (45)
Issuance of common stock upon exercise of stock options   $ 1   750       751
Issuance of common stock upon exercise of stock options (in shares)   263,604            
Share-based compensation       2,845       2,845
Cashless exercise of pre-funded warrants   $ 6   (6)        
Cashless exercise of pre-funded warrants (in shares)   5,525,267            
Other comprehensive income         143     143
Net loss           (31,108)   (31,108)
Balance ending at Dec. 31, 2024   $ 61   460,016 64 (360,552)   99,589
Balance ending (in shares) at Dec. 31, 2024   60,534,695            
Balance beginning at Jun. 30, 2024   $ 53   450,473 (79) (329,444)   121,003
Balance beginning (in shares) at Jun. 30, 2024   53,245,824            
Net loss               (74,400)
Balance ending at Jun. 30, 2025   $ 87   565,903 (7) (403,856)   $ 162,127
Balance ending (in shares) at Jun. 30, 2025   86,995,985           86,995,985
Balance beginning at Sep. 30, 2024   $ 55   457,919 289 (344,822)   $ 113,441
Balance beginning (in shares) at Sep. 30, 2024   55,394,338            
Issuance of common stock upon exercise of stock options   $ 1   657       658
Issuance of common stock upon exercise of stock options (in shares)   225,363            
Share-based compensation       1,445       1,445
Cashless exercise of pre-funded warrants   $ 5   (5)        
Cashless exercise of pre-funded warrants (in shares)   4,914,994            
Other comprehensive income         (225)     (225)
Net loss           (15,730)   (15,730)
Balance ending at Dec. 31, 2024   $ 61   460,016 64 (360,552)   99,589
Balance ending (in shares) at Dec. 31, 2024   60,534,695            
Balance beginning at Jun. 30, 2025   $ 87   565,903 (7) (403,856)   $ 162,127
Balance beginning (in shares) at Jun. 30, 2025   86,995,985           86,995,985
Issuance of common stock upon exercise of stock options   $ 1   798       $ 799
Issuance of common stock upon exercise of stock options (in shares)   328,134           328,134
Share-based compensation       5,942       $ 5,942
Cashless exercise of pre-funded warrants   $ 8   (8)        
Cashless exercise of pre-funded warrants (in shares)   8,223,879            
Other comprehensive income         54     54
Net loss           (40,924)   (40,924)
Balance ending at Dec. 31, 2025   $ 96   572,635 47 (444,780)   $ 127,998
Balance ending (in shares) at Dec. 31, 2025   95,547,998           95,547,998
Balance beginning at Sep. 30, 2025   $ 91   569,034 49 (422,006)   $ 147,168
Balance beginning (in shares) at Sep. 30, 2025   91,036,700            
Issuance of common stock upon exercise of stock options   $ 1   194       195
Issuance of common stock upon exercise of stock options (in shares)   72,227            
Share-based compensation       3,411       3,411
Cashless exercise of pre-funded warrants   $ 4   (4)        
Cashless exercise of pre-funded warrants (in shares)   4,439,071            
Other comprehensive income         (2)     (2)
Net loss           (22,774)   (22,774)
Balance ending at Dec. 31, 2025   $ 96   $ 572,635 $ 47 $ (444,780)   $ 127,998
Balance ending (in shares) at Dec. 31, 2025   95,547,998           95,547,998